NASDAQ · Medical - Devices

CLPT (CLPT) Stock

$14.14 -2.68% NASDAQ: CLPT Healthcare

Valuation

MetricValue
Price$14.14
Market Cap$424.05M
P/E Ratio-13.09
P/B Ratio12.48
P/S Ratio8.60
EPS (TTM)$0.00
52-Week High$30.10
52-Week Low$8.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-92.86%
ROA-26.53%
ROCE-85.71%
Gross Margin-64.86%
Operating Margin-64.86%
Net Margin-71.57%
Debt/Equity3.37
Current Ratio5.82

Annual Financials (USD)

Metric20212022202320242025
Revenue$16.0M$21.0M$24.0M$31.0M$37.0M
Operating Profit$-13.0M$-16.0M$-22.0M$-20.0M$-24.0M
Net Profit$-14.0M$-16.0M$-22.0M$-19.0M$-26.0M
EPS$-0.69$-0.68$-0.90$-0.70$-0.90
Op Margin-82.0%-79.5%-93.7%-62.9%-65.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$66.0M$55.0M$43.0M$39.0M$98.0M
Total Liabilities$17.0M$19.0M$21.0M$14.0M$70.0M
Cash$54.0M$28.0M$23.0M$20.0M$46.0M
Borrowings$12.0M$12.0M$14.0M$4.0M$58.0M

Latest News

Clearpoint Neuro Insider Sold Shares Worth $387,600, According to a Recent SEC Filing MT Newswires · Jul 2, 2026 ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains? Zacks · Jun 18, 2026 ClearPoint Neuro Shares Jump as FDA Progress for UniQure Therapy Highlights Platform Value InvestorsHub · Jun 17, 2026 ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint ACCESS Newswire · May 27, 2026 How The ClearPoint Neuro (CLPT) Narrative Is Shifting On Partnerships Valuation And FDA Risks Simply Wall St. · May 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-16.0M$-14.0M$-9.0M$-24.0M
Investing Cash Flow$0$-11.0M$8.0M$-1.0M$0
Financing Cash Flow$0$0$0$0$-2.0M
Net Cash Flow$34.0M$-26.0M$-4.0M$-3.0M$27.0M
Free Cash Flow$-13.0M$-16.0M$-14.0M$-9.0M$-24.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-6.87%
Quick Ratio5.09
Interest Coverage-12.00
Return 1Y25.13%
Return 3Y113.72%
Return 5Y-4.60%

Ownership

Insiders Held5.48%
Institutions Held50.62%
Institutions Float Held53.55%
Institutional HolderSharesReport Date
Blackrock Inc.2,082,7502026-03-31
MAK Capital One LLC1,901,4892026-03-31
Vanguard Capital Management LLC1,243,6152026-03-31
Geode Capital Management, LLC705,7202026-03-31
State Street Corporation679,8192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AKBA $1.31 -0.76% -45.00 $351.42M 0.00%
AVNS $24.99 +0.04% 19.96 $1.17B 0.00%
CMPSCOMPASS Pathways plc $13.31 -0.60% -6.19 $1.28B 0.00%
CTKB $4.38 -1.79% -7.25 $565.64M 0.00%
LAB $0.87 -3.27% -5.30 $339.79M 0.00%

About CLPT

CLPT is led by CEO Joseph Michael Burnett, employs 115 people, headquartered in US, publicly traded since 2012.

CLPT stock trades at $14.14 with a market capitalization of $424.05M. The stock is valued at a price-to-earnings (P/E) ratio of -13.09, price-to-book of 12.48, price-to-sales of 8.60. Over the past 52 weeks the stock has ranged between $8.27 and $30.10, and currently trades 53.0% below its 52-week high.

On profitability, CLPT generates a return on equity (ROE) of -92.86%, return on capital employed of -85.71%, an operating margin of -64.86%, a net profit margin of -71.57%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides